382 related articles for article (PubMed ID: 19604403)
1. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
BMC Neurol; 2009 Jul; 9():32. PubMed ID: 19604403
[TBL] [Abstract][Full Text] [Related]
2. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.
Jones LL; Margolis RU; Tuszynski MH
Exp Neurol; 2003 Aug; 182(2):399-411. PubMed ID: 12895450
[TBL] [Abstract][Full Text] [Related]
3. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue.
Tang X; Davies JE; Davies SJ
J Neurosci Res; 2003 Feb; 71(3):427-44. PubMed ID: 12526031
[TBL] [Abstract][Full Text] [Related]
4. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.
Jones LL; Yamaguchi Y; Stallcup WB; Tuszynski MH
J Neurosci; 2002 Apr; 22(7):2792-803. PubMed ID: 11923444
[TBL] [Abstract][Full Text] [Related]
5. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.
Davies JE; Tang X; Denning JW; Archibald SJ; Davies SJ
Eur J Neurosci; 2004 Mar; 19(5):1226-42. PubMed ID: 15016081
[TBL] [Abstract][Full Text] [Related]
6. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition.
Jones LL; Sajed D; Tuszynski MH
J Neurosci; 2003 Oct; 23(28):9276-88. PubMed ID: 14561854
[TBL] [Abstract][Full Text] [Related]
7. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.
McKeon RJ; Jurynec MJ; Buck CR
J Neurosci; 1999 Dec; 19(24):10778-88. PubMed ID: 10594061
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan.
Meyer-Puttlitz B; Junker E; Margolis RU; Margolis RK
J Comp Neurol; 1996 Feb; 366(1):44-54. PubMed ID: 8866845
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin-mediated preservation of the white matter in rat spinal cord injury.
Vitellaro-Zuccarello L; Mazzetti S; Madaschi L; Bosisio P; Gorio A; De Biasi S
Neuroscience; 2007 Feb; 144(3):865-77. PubMed ID: 17141961
[TBL] [Abstract][Full Text] [Related]
10. Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.
Andrews EM; Richards RJ; Yin FQ; Viapiano MS; Jakeman LB
Exp Neurol; 2012 May; 235(1):174-87. PubMed ID: 21952042
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive atlas of Aggrecan, Versican, Neurocan and Phosphacan expression across time in wildtype retina and in retinal degeneration.
Matsuyama A; Kalargyrou AA; Smith AJ; Ali RR; Pearson RA
Sci Rep; 2022 May; 12(1):7282. PubMed ID: 35508614
[TBL] [Abstract][Full Text] [Related]
12. Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone.
Beggah AT; Dours-Zimmermann MT; Barras FM; Brosius A; Zimmermann DR; Zurn AD
Neuroscience; 2005; 133(3):749-62. PubMed ID: 15896911
[TBL] [Abstract][Full Text] [Related]
13. Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
Brain; 2007 Apr; 130(Pt 4):940-53. PubMed ID: 17314203
[TBL] [Abstract][Full Text] [Related]
14. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.
Moon LD; Asher RA; Fawcett JW
J Neurosci Res; 2003 Jan; 71(1):23-37. PubMed ID: 12478611
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal distribution of chondroitin sulfate proteoglycans after optic nerve injury in rodents.
Pearson CS; Solano AG; Tilve SM; Mencio CP; Martin KR; Geller HM
Exp Eye Res; 2020 Jan; 190():107859. PubMed ID: 31705897
[TBL] [Abstract][Full Text] [Related]
16. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes.
Smith GM; Strunz C
Glia; 2005 Nov; 52(3):209-18. PubMed ID: 15968632
[TBL] [Abstract][Full Text] [Related]
17. Intraventricular hemorrhage induces deposition of proteoglycans in premature rabbits, but their in vivo degradation with chondroitinase does not restore myelination, ventricle size and neurological recovery.
Vinukonda G; Zia MT; Bhimavarapu BB; Hu F; Feinberg M; Bokhari A; Ungvari Z; Fried VA; Ballabh P
Exp Neurol; 2013 Sep; 247():630-44. PubMed ID: 23474192
[TBL] [Abstract][Full Text] [Related]
18. Chondroitin sulphate proteoglycans in the CNS injury response.
Morgenstern DA; Asher RA; Fawcett JW
Prog Brain Res; 2002; 137():313-32. PubMed ID: 12440375
[TBL] [Abstract][Full Text] [Related]
19. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.
Massey JM; Amps J; Viapiano MS; Matthews RT; Wagoner MR; Whitaker CM; Alilain W; Yonkof AL; Khalyfa A; Cooper NG; Silver J; Onifer SM
Exp Neurol; 2008 Feb; 209(2):426-45. PubMed ID: 17540369
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment.
Iaci JF; Vecchione AM; Zimber MP; Caggiano AO
J Neurotrauma; 2007 Nov; 24(11):1743-59. PubMed ID: 18001203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
